Pricing

Priced against the value of the batch.

A failed API campaign costs far more than the software that prevents it. Polymorra is priced per train, per plant, or as an enterprise agreement with outcome components.

$13kper train / month
$85kper plant / month
15-20%annual prepay discount

Pricing

Land on one train. Expand to the plant.

Pricing follows the value of the batch: per reactor or crystallizer train, per plant, or an enterprise agreement with outcome components.

Line

Manufacturers validating ROI on the wedge workflow.

$13,000

per reactor or crystallizer train / month

  • Reaction-control, crystallization/polymorph-control, or PAT-sensing AI for one train
  • Plant-edge runtime with validated model versioning
  • Connectors for one DCS, one PAT stack, and one MES
  • Review console for chemists and PAT engineers
  • Part 11 audit trail from day one
Start a line pilot

Enterprise

CDMOs and pharma networks standardizing on Polymorra.

Custom

land $600k – $7M ACV

  • Multi-site deployment and plant-edge fleet management
  • Custom route, crystallization, and impurity models
  • Validation support and qualification documentation
  • On-prem or hybrid deployment with NVIDIA AI Enterprise
  • SLAs, dedicated solutions engineering, and outcome pricing
Talk to sales

Built for the plants that make the world’s small molecules

  • Branded pharma
  • Generics
  • CDMOs
  • Fine chemicals
  • Peptide APIs
  • High-potency APIs
  • Continuous plants

How it works

Land on one train, expand to the plant

Almost every deployment starts as a single-train Line subscription on the workflow that hurts most. When the metric moves, expanding to Plant is a commercial change, not a re-implementation.

  • No rip-and-replace of your DCS, PAT, or MES
  • Annual prepay carries a 15–20% discount
  • Enterprise agreements can link a fee component to outcomes

Compare

What each plan includes

CapabilityLinePlantEnterprise
Trains coveredOneAll in siteAll sites
Agents includedOne workflowAll sevenAll seven + custom
Digital twinYesYes + custom routes
Part 11 audit trailYesYesYes
Fleet managementSiteMulti-site
Validation supportTemplatesGuidedDedicated
SupportBusiness hours24/724/7 + SLA
DeploymentPlant edgePlant edgeOn-prem / hybrid

Plant-edge console

One screen for the batch that is running right now

Supersaturation, particle size distribution, predicted polymorph, impurity trajectory, and the next control move — with the evidence behind each number.

Polymorra plant-edge console showing live supersaturation, particle size distribution, predicted polymorphic form, and impurity trajectory for a running crystallization, with the recommended next control move.

Enterprise

Built for multi-site pharma and CDMO networks

Multi-site deployment, plant-edge fleet management, custom route and crystallization models, validation support, and on-prem or hybrid installation with NVIDIA AI Enterprise.

Fleet of plant edges

Manage models, autonomy levels, and versions across every train in every site from one control plane.

Validation package

Qualification documentation, model version locks, and change-control artifacts your quality unit can review.

Outcome-linked pricing

Enterprise agreements can tie a component of fees to polymorph consistency, yield, or reprocessing reduction.

Dedicated engineering

Solutions engineers who speak crystallization, PAT, and GMP — not just software.

Integrations

Connects to the systems already running your plant

Polymorra reads and writes through the reactor DCS, PAT instruments, crystallizer and isolation skids, historians, and MES you already validated.

Reactor control & DCS

Emerson DeltaVSiemens PCS 7Honeywell ExperionOPC UAModbus/TCP

PAT & analytics

Mettler-Toledo FBRMPVM in-situ imagingReactIREndress+Hauser RamanNIRHPLC / XRPD imports

Isolation & drying

Nutsche filter-dryersCentrifugesAgitated dryersConical millsMicronizers

MES, historian & quality

Körber PAS-XEmerson SyncadeOSIsoft PILIMSeBR / QMS exports

Trust & compliance

Validated for GMP manufacturing

Polymorra is engineered for regulated drug-substance production: grounded outputs, immutable audit trails, graduated autonomy, and validation documentation from day one.

21 CFR Part 11

Immutable, validated audit log for every agent perception, recommendation, and control action, with e-signature-ready review flows.

GMP / ICH Q7

Change control, validated model versioning, and deployment documentation designed for drug-substance manufacturing.

SOC 2

SOC 2 Type I in progress, Type II on the roadmap; SSO/RBAC, encryption in transit and at rest. [ASPIRATIONAL]

Route & IP protection

Per-tenant isolation of routes, recipes, spectra, and crystal images. No cross-tenant training. On-prem option.

Graduated autonomy

Shadow → assist → bounded auto-control. Every autonomy level is explicitly configured, bounded, and revocable.

Grounded outputs

Every recommendation cites the spectra, images, telemetry, SOP, or specification it was derived from.

Plant-edge first

Inference runs on-site so control loops survive network loss; cloud is for training, fleet, and analytics.

Human-in-the-loop

Chemist and QA checkpoints are first-class: approve, correct, or reject — and every correction trains the models.

Voices from the plant

What operators say

Composite quotes from design-partner discovery interviews. [PLACEHOLDER — to be replaced with named references post-pilot]

“The crystallization step is where our campaigns live or die. Seeing supersaturation, particle size, and predicted polymorph in one place — and having the profile adjust itself — is what we have wanted for twenty years.”
Crystallization & PAT EngineerTop-20 branded pharma · API site
“We do not want another dashboard. We want the batch to come out right and the record to be reviewable by exception. That is the only pitch that gets past QA.”
QA / Regulatory ManagerGeneric API manufacturer
“Tech transfer is our bottleneck. If the twin can predict the plant crystal from the lab crystal, that is worth more than the software costs.”
API Manufacturing DirectorGlobal CDMO

FAQ

Frequently asked questions

No — a GMP plant deployment is never self-serve. We run a paid, scoped pilot on one train with an agreed success metric, which is the fastest honest way to find out whether Polymorra works on your route.

Number of trains, number of agents, PAT instrument coverage, deployment model (plant edge vs on-prem), validation support depth, and whether the agreement includes outcome-linked components.

Standard DCS, PAT, historian, and MES connectors are included. Bespoke connectors to unusual or legacy systems are scoped as a one-time engineering item.

Both — in a deliberate order. Polymorra starts in shadow mode (perceive only), moves to assist (recommend, chemist approves), then to bounded auto-control on qualified trains where setpoint moves stay inside validated control windows. Every level is configured per train and revocable.

Polymorra is built for GMP (ICH Q7) and 21 CFR Part 11: immutable audit trail, validated model version locks with rollback, change control, grounded and citable outputs, and human-in-the-loop checkpoints. We ship a validation package and support IQ/OQ/PQ activities with your quality unit.

API or OPC access to your reactor DCS, PAT instruments (Raman, FBRM, PVM, NIR), crystallizer and isolation skids, and MES or historian — plus a train with enough campaign volume for clear ROI.

No. Per-tenant isolation of routes, recipes, spectra, and crystal images is enforced at the data and model layer. Cross-site benchmarks are opt-in and de-identified.

Get a number for your plant.

Start with one crystallizer or reactor train. Prove polymorph, yield, and reprocessing ROI in a validation-friendly pilot. Then expand across the plant.